The monthly treatment cost of sunvozertinib generally ranges from1500 to 4500 USD, with the specific price varying according to factors such as medication dosage, medical insurance policies and regional differences. Patients must take the medicine strictly as directed by a physician, and it is recommended to obtain a personalized cost evaluation through formal medical institutions or doctors.
Key Factors Affecting the Price
Medication dosage
Dosage variations may be required for different indications or disease severity, which directly impacts the monthly cost. For example, some patients may need dosage adjustments based on body weight or treatment efficacy, leading to potential cost fluctuations.
Medical insurance policies
If sunvozertinib is included in the local medical insurance catalog or special reimbursement policies, patients' out-of-pocket proportion will be significantly reduced. It is advisable to consult the local medical insurance department or hospital pharmacy for the latest reimbursement details.
Drug purchase channels
Prices may vary across hospitals, designated pharmacies and charitable drug donation programs. Some programs provide assistance for low-income patients, which can further ease the financial burden.
Notes
Take the medicine as directed
Sunvozertinib is a prescription drug and must be prescribed based on the doctor's assessment of the patient's condition. Do not adjust the dosage or stop taking the medicine without authorization.
Regular follow-up visits
Efficacy and adverse effects need to be monitored during treatment, and doctors may optimize the treatment plan based on the monitoring results, which may in turn affect the cost.
Multi-channel consultation
Obtain the latest price, drug donation policies or patient assistance programs through attending physicians, hospital pharmacy departments or the official channels of pharmaceutical manufacturers.
Patients facing financial pressure may apply for medication support from medical institutions or public welfare organizations, and at the same time, prioritize purchasing drugs at medical insurance designated institutions to cut down expenses.
